Home Submit URL Add to Favorite Contact
           29 April, 2024
 
    
Business » Biotechnology and Pharmaceuticals » Pharmaceuticals » Biopharmaceuticals

UPDATE INFO | REPORT BROKEN LINK

Serono SA.

Popularity:    Hit: 697
Details:
Specializing in multiple sclerosis, fertility, growth therapies and AIDS wasting. Includes company history and milestones. Includes products, pipeline, investor and media details, with headquarters in Geneva, Switzerland. (NYSE: SRA)
URL: http://www.serono.com/
Title: Merck Serono S.A. - Home
Image:
Description: Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - Serono SA.. Specializing in multiple sclerosis, fertility, growth therapies and AIDS wasting.
Specialized in: Merck - Innovation

Related Sites 
Pharmos Corporation (Popularity: ): Develops and commercializes products for the central nervous system (CNS), neurological, ophthalmic and other healthcare markets.
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
Generex Biotechnology (Popularity: ): Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
Lybradyn: Microbial Natural Products (Popularity: ): Focused on discovering and developing natural products from living organisms to serve the pharmaceutical and fine chemical industries. Includes explanation ...
Morphochem (Popularity: ): Focuses on finding therapeutic agents to treat diseases. Particular emphasis is on protein to protein interactions.
Modular Genetics, Inc. (Popularity: ): Supporting basic research, drug design, drug screening and chemical synthesis.
Myogen, Inc. (Popularity: ): Develops therapeutic drugs to treat heart failure using expertise in molecular cardiology and a human heart tissue bank. Includes product ...
Virax Holdings, Ltd. (Popularity: ): Developing therapeutics for autoimmune diseases, AIDS, cancers, infectious diseases based on patented Co-X-Gene platform technology co-expressing antibodies and T cells. ...
Replidyne (Popularity: ): In the process of creating bacteria that will block infectious disease DNA replication. Includes information about the company, news releases ...
Intra-Cellular Therapies, Inc. (Popularity: ): Developing novel drugs against targets inside nerve cells to treat CNS disorders. Includes therapeutic projects, target biochemistry, corporate data and ...


Popular Sites
African Reptiles and Venom (Popularity: ): Supplier of snake venom for anti-serum production, with captive reptile breeding for pet trade. Offer film work, field tours, courses ...
Aphios Corp. (Popularity: ): Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product ...
Bavarian Nordic (Popularity: ): Developer and manufacturer offering prevention and treatment of infectious diseases, with pre-clinical research programs, and has established products for HIV ...
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
BioMarin Pharmaceutical Inc. (Popularity: ): Researches and develops therapies for debilitating, fatal, chronic genetic disorders causing enzyme deficiency of carbohydrate metabolism, such as phenylketonuria. Headquarters ...


Related Press
Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis (Popularity: ): Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment has been completed in the REFLEX ...